Questions from the audience

Area of Science:

• Dermatology
• Immunology

Background:

• Recurring genital warts present a clinical challenge.
• Imiquimod is an immune response modifier used in dermatology.

Purpose of the Study:

• To address audience questions regarding imiquimod for recurring genital warts.
• To explore clinical efficacy, side effects, recurrence, and future applications of imiquimod.

Main Methods:

• A Q&A session during a seminar at the 6th Congress of European Academy of Dermatology and Venereology.
• Discussion focused on audience inquiries about imiquimod's use.

Main Results:

• Key issues raised included the clinical efficacy of imiquimod.
• Side effects and recurrence rates associated with imiquimod treatment were discussed.
• Potential future applications of imiquimod were explored.

Conclusions:

• Audience engagement highlighted critical aspects of imiquimod therapy for recurring genital warts.
• Further insights into imiquimod's role in managing genital warts were provided through expert discussion.